Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 166 AL 180

[Dementia of the Alzheimer type: non-drug and drug therapy]

Kressig RW.

Ther Umsch. 2015 Apr;72(4):233-8. doi: 10.1024/0040-5930/a000670.

[Behavioral and psychological symptoms of dementia (BPSD): how to proceed]

Savaskan E.

Ther Umsch. 2015 Apr;72(4):255-60. doi: 10.1024/0040-5930/a000673.

Tailored nutritional guidance for home-dwelling AD families: the Feasibility of and Elements Promoting Positive Changes in Diet (NuAD-Trial)

Puranen TM, Pitkala KH, Suominen MH.

J Nutr Health Aging. 2015 Apr;19(4):454-9. doi: 10.1007/s12603-014-0567-4.

View of excellent ROAD from the CAR

Lahiri DK.

Curr Alzheimer Res. 2015;12(2):96-9. doi: 10.2174/156720501202150224091751.

Latent change score modeling as a method for analyzing the antidepressant effect of a psychosocial intervention in Alzheimer's disease

Werheid K, Köhncke Y, Ziegler M, Kurz A.

Psychother Psychosom. 2015;84(3):159-66. doi: 10.1159/000376583. Epub 2015 Mar 28.

Rivastigmine for Alzheimer's disease

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3.

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis

Matsunaga S, Kishi T, Iwata N.

PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal.pone.0123289. eCollection 2015.

Professional Care Team Burden (PCTB) scale - reliability, validity and factor analysis

Auer S, Graessel E, Viereckl C, Kienberger U, Span E, Luttenberger K.

Health Qual Life Outcomes. 2015 Feb 7;13:17. doi: 10.1186/s12955-014-0199-8.

Latrepirdine for Alzheimer's disease

Chau S, Herrmann N, Ruthirakuhan MT, Chen JJ, Lanctôt KL.

Cochrane Database Syst Rev. 2015 Apr 21;2015(4):CD009524. doi: 10.1002/14651858.CD009524.pub2.

The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial

Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M.

Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z.

A web-based psychoeducational program for informal caregivers of patients with Alzheimer's disease: a pilot randomized controlled trial

Cristancho-Lacroix V, Wrobel J, Cantegreil-Kallen I, Dub T, Rouquette A, Rigaud AS.

J Med Internet Res. 2015 May 12;17(5):e117. doi: 10.2196/jmir.3717.

Adaptive, dose-finding phase 2 trial evaluating the safety and efficacy of ABT-089 in mild to moderate Alzheimer disease

Lenz RA, Pritchett YL, Berry SM, Llano DA, Han S, Berry DA, Sadowsky CH, Abi-Saab WM, Saltarelli MD.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):192-9. doi: 10.1097/WAD.0000000000000093.

Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature

Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I.

Int J Neuropsychopharmacol. 2015 May 19;18(10):pyv055. doi: 10.1093/ijnp/pyv055.

Posterior cortical atrophy: an atypical variant of Alzheimer disease

Suárez-González A, Henley SM, Walton J, Crutch SJ.

Psychiatr Clin North Am. 2015 Jun;38(2):211-20. doi: 10.1016/j.psc.2015.01.009. Epub 2015 Mar 12.

Neuropsychiatric management of young-onset dementias

Shinagawa S.

Psychiatr Clin North Am. 2015 Jun;38(2):323-31. doi: 10.1016/j.psc.2015.01.004. Epub 2015 Feb 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias